Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEPDC1-AS2 is an uncharacterized lncRNA transcribed antisense to the DEPDC1 gene. No validated function, biological pathway, or disease association has been published as of the current date. Related lncRNAs in the DEPDC1 locus are active in cancer, but this specific molecule lacks experimental evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEPDC1 antisense RNA 2 (DEPDC1-AS2).